Paciaroni, Katia, et al. “THE Co-Occurrence of Jak2 Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated With Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.: Dual Myeloid Disorder Treated With Two Drug Association”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 17, no. 1, Feb. 2025, p. e2025023, doi:10.4084/MJHID.2025.023.